Compounds > garenoxacin
Page last updated: 2024-09-03

garenoxacin and Haemophilus Infections

garenoxacin has been researched along with Haemophilus Infections in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Imuta, N; Iuchi, H; Kiyama, S; Kurono, Y; Nishi, J; Ohori, J; Yamashita, M1
Hosono, H; Ishida, T; Izumikawa, K; Kohno, S; Kushimoto, S; Miyashita, N; Watanabe, A1
Aracil, B; Campos, J; Cantón, R; Pérez-Vázquez, M; Román, F1
Fritsche, TR; Jones, RN; Sader, HS; Stilwell, MG1
Bell, JM; Jones, RN; Turnidge, JD1

Other Studies

5 other study(ies) available for garenoxacin and Haemophilus Infections

ArticleYear
Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae.
    BMC microbiology, 2021, 05-14, Volume: 21, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus pyogenes

2021
Efficacy and safety of garenoxacin tablets on bacterial pneumonia: postmarketing surveillance in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:9

    Topics: Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Pneumococcal Infections; Pneumonia, Bacterial; Product Surveillance, Postmarketing; Prospective Studies; Quinolines; Streptococcus pneumoniae; Tablets

2014
In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Amino Acid Substitution; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutation; Quinolones; Reverse Transcriptase Polymerase Chain Reaction

2003
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:1

    Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Hospitalization; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae

2007
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.
    International journal of antimicrobial agents, 2002, Volume: 19, Issue:2

    Topics: Anti-Infective Agents; Asia; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Indoles; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Population Surveillance; Prevalence; Quinolones; Respiratory Tract Diseases; South Africa; Streptococcus pneumoniae

2002